Can systemic infectious or post-infectious inflammation contribute to cognitive dysfunction?

Systemic infection and persistent post-infectious illness are clinically relevant to cognition, particularly in later life, but the evidence supports a plausible, multifactorial contribution of brain immune signaling rather than a proven single causal pathway.

Clinical and cognitive evidence

• Post-COVID cohorts link cognitive impairment with CSF immune alterations, blood–brain barrier dysfunction, and increased TSPO-PET signal compatible with glial or neurovascular activation. However, TSPO is not microglia-specific, and some studies find no PET or CSF abnormalities.
• Longitudinal evidence more firmly supports adverse cognitive associations: infections are associated with later dementia, with larger associations reported after sepsis and pneumonia in a UK cohort of nearly 1 million adults aged ≥65 years.
• Delirium is a particularly important clinical marker. A meta-analysis of 23 studies found worse long-term cognition after delirium, and cohort evidence associates it with subsequent mild cognitive impairment, dementia, and faster decline in people with existing dementia pathology.

Mechanistic interpretation

• Peripheral inflammatory signals may act through the neurovascular interface, altered barrier integrity, and resident CNS immune cells. Yet a human interferon-α challenge markedly increased serum IL-6 without a corrected TSPO-PET change, underscoring that blood cytokines do not directly measure CNS immune activity.
• Aging and neurodegeneration may “prime” microglia, allowing later systemic immune challenges to generate amplified central cytokine responses, synaptic dysfunction, and acute cognitive deterioration. Amyloid-associated microglial activation and sustained inflammatory signaling are also linked mechanistically to tau-related changes and synaptic loss, although microglial effects vary by disease stage.

Clinical implications

• For a 77-year-old man, infection-associated delirium or cognitive change warrants attention because it may identify heightened vulnerability and predict poorer subsequent cognitive trajectory. Hypoxia, vascular injury, medications, ICU exposure, frailty, and underlying neurodegeneration may contribute alongside immune pathways.

Bottom line

• Brain immune signaling is a biologically credible contributor to post-infectious cognitive dysfunction, especially in older vulnerable brains, but human evidence remains heterogeneous and largely associative rather than definitive proof of causation.